Brief #02913Updated 18 NOV 2025PALO ALTOGVSERIES A
Employbl DossierBitterroot Bio
Bitterroot Bio leverages the power of immunotherapy to develop and deliver novel medicines for cardiovascular disease.
- Founded
- 2021
- Headcount
- 12
- Open roles
- 1
- Last raised
- Series A · $145M
Section II — RestrictedMembers only
- Engineering interview process at Bitterroot Bio
- Tech stack & infrastructure choices
- Culture & day-to-day work style
- Why join now vs. 6 months from now
- Hiring focus & open headcount by team
- Comp philosophy and band context
7-day free trial · $25/mo · cancel anytime
